Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study.

TitleThe use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study.
Publication TypeJournal Article
Year of Publication1981
AuthorsPhilbin DM, Moss J, Akins CW, Rosow CE, Kono K, Schneider RC, VerLee TR, Savarese JJ
Date Published1981 Sep
KeywordsBlood Pressure, Cardiac Output, Central Venous Pressure, Cimetidine, Clinical Trials as Topic, Coronary Artery Bypass, Diphenhydramine, Double-Blind Method, Drug Antagonism, Guanidines, Histamine Antagonists, Histamine H1 Antagonists, Histamine H2 Antagonists, Humans, Middle Aged, Morphine, Placebos, Preanesthetic Medication, Vascular Resistance

High doses of morphine can produce significant cardiovascular effects generally attributed to histamine release. The authors examined the possibility that H1 and H2 histamine antagonists might prove beneficial in preventing these responses. In a randomized double-blind study, four groups of 10 patients each received 1 mg/kg morphine and either a placebo, diphenhydramine (H1), cimetidine (H2), or both of the histamine antagonists. The morphine-placebo group demonstrated a marked elevation in plasma histamine levels (880 +/- 163 to 7437 +/- 2684 pg/ml), a decrease in systemic vascular resistance (SVR) (15.5 to 9.0 l torr/(l . min-1) and diastolic BP (71 +/- 3 to 45 +/- 4 torr) and an increase in cardiac index (CI) (2.4 +/- 0.2 to 3.0 +/- 0.21 . min-1 . m-2). The administration of either cimetidine or diphenhydramine with morphine provided minimal protection. Those patients who received morphine and both antagonists demonstrated significant attenuation of these responses (CI 2.5 +/- 0.2 to 2.5 +/- 0.1 l . min-1 . m-2; SVR 17.4 to 14.6 torr/(l . min-1) although plasma histamine levels showed a comparable increase (1059 +/- 222 to 7653 +/- 4242 pg/ml). These data demonstrate directly that many of the hemodynamic effects of morphine can be attributed to histamine release. They further demonstrate that significant hemodynamic protection can be obtained by the use of histamine antagonists and the combination of H1 and H2 antagonists is superior to either given alone.

Alternate JournalAnesthesiology
PubMed ID6115596